Drug: Placebo

DRUG8 trials

Conditions

Acute Myocardial InfarctionFood AllergyHealthy Adult VolunteersHealthy AdultsModerate to Severe Plaque PsoriasisNon-alcoholic Fatty Liver DiseasePeriumbilical Subcutaneous Adipose Tissue ReductionRelapsing Remitting Multiple Sclerosis

Phase 1

Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers

CompletedNCT03748758

Novus Therapeutics, IncHealthy Adult Volunteers

Start: 2018-11-27End: 2019-03-20Updated: 2020-02-25

Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults

CompletedNCT03828149

Novus Therapeutics, IncHealthy Adults

Start: 2019-02-08End: 2019-03-07Updated: 2019-12-30

Phase 2

A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction

WithdrawnNCT01311518

RegeneRx Biopharmaceuticals, Inc.Acute Myocardial Infarction, ST Elevation Myocardial Infarction, STEMI

Start: 2019-07-31End: 2020-07-31Updated: 2021-09-22

Dose Ranging Study

CompletedNCT01802723

Neothetics, IncPeriumbilical Subcutaneous Adipose Tissue Reduction

Start: 2013-02-28End: 2013-10-31Updated: 2015-03-26

Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease

CompletedNCT02303314

Shiraz University of Medical SciencesNon-alcoholic Fatty Liver Disease

Start: 2014-11-30End: 2017-09-30Updated: 2017-09-25

E-B-FAHF-2, Multi OIT and Xolair for Food Allergy

CompletedNCT06103656

New York Medical CollegeFood Allergy

Start: 2016-08-20End: 2021-02-22Updated: 2024-03-25

Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis

RecruitingNCT07672561

Zhejiang Wenda Pharma Technology LTD.Moderate to Severe Plaque Psoriasis

Start: 2026-03-18End: 2027-07-30Target: 375Updated: 2026-06-29

Phase 4

Impact of Vitamin A on Multiple Sclerosis (MS)

NCT01417273

Tehran University of Medical SciencesRelapsing Remitting Multiple Sclerosis